The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy.
 
Kunihiro Matsuzaki
No Relationships to Disclose
 
Yuka Ito
No Relationships to Disclose
 
Mamoru Fukuda
No Relationships to Disclose
 
Kentaro Sakamaki
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Mitsubishi Tanabe Pharma; Taiho Pharmaceutical
 
Masahiko Ando
No Relationships to Disclose
 
Yasuyuki Kojima
No Relationships to Disclose
 
Naoki Furuya
No Relationships to Disclose
 
Takashi Tsuda
No Relationships to Disclose
 
Hiroko Minatogawa
No Relationships to Disclose
 
Yasushi Ichikawa
No Relationships to Disclose
 
Ichiro Ohta
No Relationships to Disclose
 
Saori Takei
No Relationships to Disclose
 
Yutaka Tokuda
Honoraria - AstraZeneca; Chugai Pharma; Covidien; Daiichi Sankyo; Eisai; Fuji Pharma; GlaxoSmithKline; Kyowa Hakko Kirin; Meiji Seika Kaisha; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Kyowa Hakko Kirin; Novartis; Taiho Pharmaceutical; Takeda
 
Kazutaka Narui
No Relationships to Disclose
 
Ayako Tsuboya
No Relationships to Disclose
 
Takashi Suda
No Relationships to Disclose
 
Satoshi Morita
No Relationships to Disclose
 
Takeharu Yamanaka
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Narikazu Boku
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Takako Eguchi Nakajima
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical